Chemical Furnace‐Assisted Combustion Synthesis of SiC Powder With Controllable Particle Size
Journal of the American Ceramic Society · 2026-11 · 109 (11)
DOI: 10.1111/jace.71437 ↗At a glance
Journal article in Journal of the American Ceramic Society, published online on 2026-11-15. Written by Fei Li and 6 co-authors. 31 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
This study proposes a chemical furnace‐assisted combustion synthesis strategy, using a strongly exothermic Ti–C reaction system as the “chemical furnace” to input energy into a weakly exothermic Si–C reaction system. By changing the mass ratio K between the Ti–C and Si–C powders, the energy input and maximum reaction temperature can be effectively controlled, thereby enabling the controllable preparation of SiC powders with sizes ranging from the nanoscale to the micrometer scale (28.5 nm–5.4 µm) and promoting the phase transformation of SiC. The particle size, phase composition, microscopic morphology, and particle size growth mechanism of the SiC products under different K values were systematically studied.
Funding
- National Natural Science Foundation of China
Cite
APA
Li, F., Li, J., Dong, H., Zhang, J., gao, Y., Ge, Y., & Chen, K. (2026). Chemical Furnace‐Assisted Combustion Synthesis of SiC Powder With Controllable Particle Size. Journal of the American Ceramic Society, 109(11). https://doi.org/10.1111/jace.71437
Vancouver
Li F, Li J, Dong H, Zhang J, gao Y, Ge Y, et al. Chemical Furnace‐Assisted Combustion Synthesis of SiC Powder With Controllable Particle Size. Journal of the American Ceramic Society. 2026;109(11). doi:10.1111/jace.71437
BibTeX
@article{Li2026,
author = {Li, Fei and Li, Jian and Dong, Haolin and Zhang, Jie and gao, Yixuan and Ge, Yiyao and Chen, Kexin},
title = {Chemical Furnace‐Assisted Combustion Synthesis of SiC Powder With Controllable Particle Size},
journal = {Journal of the American Ceramic Society},
year = {2026},
volume = {109},
number = {11},
doi = {10.1111/jace.71437}
}
EUVIMED